Global Alzheimer's Drugs Market Report 2018-2024: Focus on Drug Class, Distribution Channel and Region - ResearchAndMarkets.com

DUBLIN--()--The "Alzheimer s Drugs Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.

The report predicts the global Alzheimer's drugs market to grow with a CAGR of 7% over the forecast period of 2018-2024. The study on Alzheimer's drugs market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2024.

The rising occurrence of neurodegenerative diseases among the elderly and a healthy support from governments across developed countries has led to the development of new drugs and therapies which has helped in the development and growth of the Alzheimer's drugs market.

Additionally lack of Duchenne muscular dystrophy (DMD) is another factor that promotes the growth of the market. The lack of DMDs extends the treatment schedule for Alzheimer's disease, which in turn, increases the healthcare costs for patients.

Among regions, North America is expected to the largest market for Alzheimer's drugs. The large number of patients suffering from the Alzheimer's disease, high purchasing power for expensive drugs and compensation policies for the treatment of this disease is likely to boost the growth in this market.

The increasing awareness about neurodegenerative diseases in Asia Pacific region will boost the growth of the global Alzheimer's drugs market in the next coming years.

Key Topics Covered

1. Preface

2. Executive Summary

3. Global Alzheimer's Drugs Market Overview

4. Global Alzheimer's Drugs Market by Drug Class

5. Global Alzheimer's Drugs Market by Distribution Channel

6. Global Alzheimer's Drugs Market by Region 2018-2024

7. Companies Covered

  • H Lundbeck A/S
  • Eisai Co Ltd
  • Ono Pharmaceutical
  • Daiichi Sankyo Company Limited
  • Johnson & Johnson
  • Merz Holding GmbH & Co KG
  • and more...

For more information about this report visit https://www.researchandmarkets.com/research/7mr5tb/global?w=4

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Alzheimer's Disease Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Alzheimer's Disease Drugs